Is the patients’ fear of cancer the main barrier to prescribing menopausal hormone therapy?
The findings indicate that MHT prescribing practices in Brazil are still significantly influenced by structural barriers in the public sector and by negative perceptions in the private sector. Interventions aimed at expanding access and educating both physicians and patients are essential to ensure safe and equitable use of MHT.
Authors
- César Eduardo Fernandes (ORCID: https://orcid.org/0000-0002-7796-6386)
- Rogério Bonassi Machado (ORCID: https://orcid.org/0000-0001-9361-0905)
- Luciano de Melo Pompei (ORCID: https://orcid.org/0000-0001-7084-037X)
- Isabella Melo Pompei (ORCID: https://orcid.org/0000-0001-9438-1163)
- Rossella E. Nappi (ORCID: https://orcid.org/0000-0002-5216-9882)
- Sabrina Lara Abonizio Magdalena (ORCID: https://orcid.org/0009-0007-8417-9392)
- Vivien Suemi Arimura (ORCID: https://orcid.org/0009-0005-6568-5180)
Institutions
- University of Pavia (IT)
- University Hospital Foundation (CA)
- Faculdade de Medicina de Jundiaí (BR)
- Faculdade de Medicina do ABC (BR)
Publication Details
- Journal
- Climacteric
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1080/13697137.2025.2560327
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00